These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26724540)

  • 1. Targeting CD44 receptor-positive lung tumors using polysaccharide-based nanocarriers: Influence of nanoparticle size and administration route.
    Jeannot V; Mazzaferro S; Lavaud J; Vanwonterghem L; Henry M; Arboléas M; Vollaire J; Josserand V; Coll JL; Lecommandoux S; Schatz C; Hurbin A
    Nanomedicine; 2016 May; 12(4):921-932. PubMed ID: 26724540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tumor efficacy of hyaluronan-based nanoparticles for the co-delivery of drugs in lung cancer.
    Jeannot V; Gauche C; Mazzaferro S; Couvet M; Vanwonterghem L; Henry M; Didier C; Vollaire J; Josserand V; Coll JL; Schatz C; Lecommandoux S; Hurbin A
    J Control Release; 2018 Apr; 275():117-128. PubMed ID: 29474960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional tumor-targeting nanocarriers based on hyaluronic acid-mediated and pH-sensitive properties for efficient delivery of docetaxel.
    Song S; Chen F; Qi H; Li F; Xin T; Xu J; Ye T; Sheng N; Yang X; Pan W
    Pharm Res; 2014 Apr; 31(4):1032-45. PubMed ID: 24154802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronan-based nanocarriers with CD44-overexpressed cancer cell targeting.
    Song S; Qi H; Xu J; Guo P; Chen F; Li F; Yang X; Sheng N; Wu Y; Pan W
    Pharm Res; 2014 Nov; 31(11):2988-3005. PubMed ID: 24842660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo biodistribution of siRNA and cisplatin administered using CD44-targeted hyaluronic acid nanoparticles.
    Ganesh S; Iyer AK; Gattacceca F; Morrissey DV; Amiji MM
    J Control Release; 2013 Dec; 172(3):699-706. PubMed ID: 24161254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic active targeting of dually integrin αvβ3/CD44-targeted nanoparticles to B16F10 tumors located at different sites of mouse bodies.
    Shi S; Zhou M; Li X; Hu M; Li C; Li M; Sheng F; Li Z; Wu G; Luo M; Cui H; Li Z; Fu R; Xiang M; Xu J; Zhang Q; Lu L
    J Control Release; 2016 Aug; 235():1-13. PubMed ID: 27235150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-targeting hybrid nanoparticles for the delivery of SN38 to Her2 and CD44 overexpressed human gastric cancer.
    Yang Z; Luo H; Cao Z; Chen Y; Gao J; Li Y; Jiang Q; Xu R; Liu J
    Nanoscale; 2016 Jun; 8(22):11543-58. PubMed ID: 27203688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodegradable nanoparticles sequentially decorated with Polyethyleneimine and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells.
    Maiolino S; Russo A; Pagliara V; Conte C; Ungaro F; Russo G; Quaglia F
    J Nanobiotechnology; 2015 Apr; 13():29. PubMed ID: 25888948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells.
    Saneja A; Nayak D; Srinivas M; Kumar A; Khare V; Katoch A; Goswami A; Vishwakarma RA; Sawant SD; Gupta PN
    Eur J Pharm Sci; 2017 Jan; 97():79-91. PubMed ID: 27989859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A facile approach for fabricating CD44-targeted delivery of hyaluronic acid-functionalized PCL nanoparticles in urethane-induced lung cancer: Bcl-2, MMP-9, caspase-9, and BAX as potential markers.
    Parashar P; Tripathi CB; Arya M; Kanoujia J; Singh M; Yadav A; Saraf SA
    Drug Deliv Transl Res; 2019 Feb; 9(1):37-52. PubMed ID: 30178279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronan magnetic nanoparticle for mitoxantrone delivery toward CD44-positive cancer cells.
    Sargazi A; Shiri F; Keikha S; Majd MH
    Colloids Surf B Biointerfaces; 2018 Nov; 171():150-158. PubMed ID: 30025377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular uptake and internalization of hyaluronan-based doxorubicin and cisplatin conjugates.
    Cai S; Alhowyan AA; Yang Q; Forrest WC; Shnayder Y; Forrest ML
    J Drug Target; 2014 Aug; 22(7):648-57. PubMed ID: 24892741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronan-Metal Gold Nanoparticle Hybrids for Targeted Tumor Cell Therapy.
    Sanfilippo V; Caruso VCL; Cucci LM; Inturri R; Vaccaro S; Satriano C
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32349323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
    Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
    Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratracheal Administration of Hyaluronan-Cisplatin Conjugate Nanoparticles Significantly Attenuates Lung Cancer Growth in Mice.
    Ishiguro S; Cai S; Uppalapati D; Turner K; Zhang T; Forrest WC; Forrest ML; Tamura M
    Pharm Res; 2016 Oct; 33(10):2517-29. PubMed ID: 27335023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual CD44 and folate receptor-targeted nanoparticles for cancer diagnosis and anticancer drug delivery.
    Lee JY; Termsarasab U; Park JH; Lee SY; Ko SH; Shim JS; Chung SJ; Cho HJ; Kim DD
    J Control Release; 2016 Aug; 236():38-46. PubMed ID: 27320169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Development of Hyaluronan/Fucoidan-Based Nanoparticles as Macrophages Targeting an Epigallocatechin-3-Gallate Delivery System.
    Ho CH; Chu PY; Peng SL; Huang SC; Lin YH
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32878305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44-Targeted Multifunctional Nanomedicines Based on a Single-Component Hyaluronic Acid Conjugate with All-Natural Precursors: Construction and Treatment of Metastatic Breast Tumors
    Fang H; Zhao X; Gu X; Sun H; Cheng R; Zhong Z; Deng C
    Biomacromolecules; 2020 Jan; 21(1):104-113. PubMed ID: 31532629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronic acid-based drug nanocarriers as a novel drug delivery system for cancer chemotherapy: A systematic review.
    Salari N; Mansouri K; Valipour E; Abam F; Jaymand M; Rasoulpoor S; Dokaneheifard S; Mohammadi M
    Daru; 2021 Dec; 29(2):439-447. PubMed ID: 34499323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine.
    Mattheolabakis G; Milane L; Singh A; Amiji MM
    J Drug Target; 2015; 23(7-8):605-18. PubMed ID: 26453158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.